BIT Capital’s Blueprint Medicines BPMC Stock Holding History

BIT Capital’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,423	Closed	-$182K	–	114
2025 Q2	$182K	Sell	1,423 -76,379	-98%	-$7.93M	0.01%	74
2025 Q1	$6.89M	Sell	77,802 -1,119	-1%	-$109K	0.59%	28
2024 Q4	$6.88M	Buy	78,921 +3,347	+4%	+$307K	0.55%	29
2024 Q3	$6.99M	Sell	75,574 -78,558	-51%	-$7.8M	0.65%	30
2024 Q2	$16.6M	Sell	154,132 -15,513	-9%	-$1.55M	1.3%	21
2024 Q1	$16.1M	Buy	169,645 +101,618	+149%	+$8.72M	1.19%	23
2023 Q4	$6.27M	Buy	68,027 +63,953	+1,570%	+$4.14M	0.62%	34
2023 Q3	$205K	Buy	4,074 +1,219	+43%	+$65.1K	0.02%	86
2023 Q2	$180K	Buy	+2,855	New	+$155K	0.02%	113

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BIT Capital's BPMC Position: Q3 2025 in Review

BIT Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,423 shares — an estimated $182K sold.

BIT Capital first reported a position in BPMC in Q2 2023 and held it in 9 quarters. The position peaked at $16.6M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

BIT Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
BIT Capital sold 1,423 Blueprint Medicines shares in Q3 2025, an estimated $182K.
BIT Capital first reported a position in Blueprint Medicines in Q2 2023 and held it in 9 quarters.
BIT Capital's Blueprint Medicines position peaked at $16.6M in Q2 2024.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on BIT Capital's 13F filing for Q3 2025, filed 10 Nov 2025.